GSA CAPITAL PARTNERS LLP - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 122 filers reported holding TG THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$191
-89.3%
22,857
-68.0%
0.02%
-91.0%
Q2 2023$1,777
+253.3%
71,518
+114.1%
0.18%
+256.0%
Q1 2023$503
-67.8%
33,411
-74.7%
0.05%
-74.2%
Q4 2022$1,560
-99.3%
131,893
+234.2%
0.19%
+525.8%
Q3 2022$234,000
+21.9%
39,466
-12.8%
0.03%
+6.9%
Q2 2022$192,000
-68.1%
45,281
-28.3%
0.03%
-64.2%
Q1 2022$601,000
+194.6%
63,184
+488.1%
0.08%
+211.5%
Q4 2021$204,000
-39.1%
10,744
+66.8%
0.03%
-52.7%
Q4 2020$335,000
-2.3%
6,442
-89.5%
0.06%
+19.6%
Q3 2019$343,00061,1150.05%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Lion Point Capital, LP 839,128$27,926,0005.24%
RA Capital Management 4,098,332$136,392,0001.89%
KLK CAPITAL MANAGEMENT LLC 45,762$1,523,0001.40%
Antara Capital LP 520,800$17,332,0001.33%
Spotlight Asset Group, Inc. 75,000$2,496,0001.24%
Nicholas Investment Partners, LP 485,838$16,169,0001.18%
MAVERICK CAPITAL LTD 3,296,451$109,706,0001.11%
SECTORAL ASSET MANAGEMENT INC 394,949$13,144,0001.09%
683 Capital Management, LLC 828,271$27,565,0001.08%
ACT CAPITAL MANAGEMENT, LLC 60,000$1,997,0001.04%
View complete list of TG THERAPEUTICS INC shareholders